Centessa Pharmaceuticals plc (CNTA)
NASDAQ·Healthcare·Biotechnology
$39.75
-0.06%
Mkt Cap $3.51B
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$38.60
Range $35.00 – $42.00
Implied Upside
-2.9%
Consensus $38.60 vs current $39.75
NASDAQ·Healthcare·Biotechnology
$39.75
-0.06%
Mkt Cap $3.51B
No recent rating data.
Price Target (16 analysts)
$38.60
Range $35.00 – $42.00
-2.9%
Consensus $38.60 vs current $39.75